Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Heart Rate Reduction by IVabradine for Improvement of ENDothELial Function in Patients With Coronary Artery Disease: the RIVENDEL Study

NCT02681978 is registered in ClinicalTrials.gov with Campus Bio-Medico University as lead sponsor.

NCT NCT02681978
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02681978 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Heart Rate Reduction by IVabradine for Improvement of ENDothELial Function in Patients With Coronary Artery Disease: the RIVENDEL Study
Lead sponsor
Campus Bio-Medico University
Phase
Phase 4
Overall status
Completed
Start date
February 28, 2014
Completion date
July 31, 2015
Enrollment
70 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

coronary artery disease